bioRASI Names Steven Trattner Vice President, Marketing

December 22, 2012

Award winning CRO seeks to accelerate growth

Aventura, FL (PRWEB) December 21, 2012

bioRASI, a full service, global Contract Research Organization (CRO) announced today that Steven Trattner has joined the company as Vice President of Marketing. bioRASI is extending its worldwide operations and deepening its areas of expertise, necessitating the creation of a senior executive position focused on strategic marketing and marketing communications. Trattner will lead these efforts while capitalizing on the significant gains bioRASI has already achieved in the areas of clinical research for generic and novel pharmaceuticals as well as biologics.

“We are fortunate to welcome an executive of Steve Trattner´s caliber to lead our Marketing,” said Dr. Boris Reznik, Chairman of bioRASI. “Steve has an extensive track record of strengthening brand awareness, accelerating revenue growth and driving broad market penetration in services industries.”

Trattner brings 25 years of in-depth marketing and operations management experience across the healthcare services industry. Prior to joining bioRASI Trattner served in senior executive roles within healthcare and pharmaceuticals services industries. Trattner holds a BS in Biomedical Communications and an MBA in Healthcare Marketing.

“I am very pleased about joining the bioRASI team and working with some of the most dedicated, knowledgeable and accomplished professionals in the CRO industry,” said Trattner. “The breadth and depth of bioRASI´s expertise in program optimization is impressive, and bioRASI´s clinical and regulatory services exceed the highest standards. It is obvious why bioRASI is routinely recognized through various quality-based awards and achievements in the pharmaceutical industry. I am eager to contribute to bioRASI´s success and dive into this intriguing market as the CRO industry continues its phenomenal growth.”

About bioRASI

bioRASI is an award-winning Full Service Global CRO providing clinical development services that optimize its sponsors´ scientific, clinical, and business results. bioRASI facilitates obtaining global marketing approval for drugs, biotherapeutics, and medical devices by delivering high quality regulatory and clinical strategies, solutions and services. The Company’s unique access to the largest facilities and patient populations all over the world saves their clients critical time. bioRASI’s services include program optimization, project management, regulatory, clinical, data management and analysis, compliance and audit. bioRASI is headquartered in Aventura, FL and has regional offices and operations across North America and around the world.

Click here for a copy of our White Paper Series.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/12/prweb10263182.htm

Source: prweb

comments powered by Disqus